| Literature DB >> 30579630 |
Alison Schroer1, Gaspard Pardon2, Erica Castillo3, Cheavar Blair3, Beth Pruitt3.
Abstract
The study of human cardiomyopathies and the development and testing of new therapies has long been limited by the availability of appropriate in vitro model systems. Cardiomyocytes are highly specialized cells whose internal structure and contractile function are sensitive to the local microenvironment and the combination of mechanical and biochemical cues they receive. The complementary technologies of human induced pluripotent stem cell (hiPSC) derived cardiomyocytes (CMs) and microphysiological systems (MPS) allow for precise control of the genetics and microenvironment of human cells in in vitro contexts. These combined systems also enable quantitative measurement of mechanical function and intracellular organization. This review describes relevant factors in the myocardium microenvironment that affect CM structure and mechanical function and demonstrates the application of several engineered microphysiological systems for studying development, disease, and drug discovery.Entities:
Keywords: Cardiac mechanobiology; Drug discovery; Heart-on-a-chip; Human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs); In vitro cardiac model; Microphysiological systems (MPS)
Mesh:
Year: 2018 PMID: 30579630 PMCID: PMC6919215 DOI: 10.1016/j.pbiomolbio.2018.12.001
Source DB: PubMed Journal: Prog Biophys Mol Biol ISSN: 0079-6107 Impact factor: 4.799